Literature DB >> 10996220

Role of NMDA receptor signaling in the regulation of inflammatory gene expression after focal brain ischemia.

S Jander1, M Schroeter, G Stoll.   

Abstract

Inflammatory mediators are involved in the pathogenesis of focal ischemic brain damage. In this study we used quantitative reverse transcriptase-polymerase chain reaction to analyze the spatiotemporal pattern of tumor necrosis factor-alpha (TNF-alpha), interleukin-1beta (IL-1beta), and inducible nitric oxide synthase (iNOS) expression in focal ischemia of the rat brain. Focal ischemia of the rat parietal cortex was induced noninvasively by photothrombosis of cortical microvessels. In a proportion of the animals NMDA receptor signaling was blocked by the noncompetitive receptor antagonist MK-801. Within 4 h after ischemia we found induction of TNF-alpha and IL-1beta mRNA not only in the infarcts but also in all representative tissue samples removed from noninfarcted frontal, lateral, and occipital cortex of the ipsilateral, but not contralateral hemisphere. Contrastingly, the expression of iNOS mRNA remained restricted to the evolving infarcts. Pretreatment with MK-801 strongly inhibited remote cytokine expression (mean reduction by 80% relative to vehicle treated animals at 4 h; P<0.001) whereas in the lesions only partial reductions in the expression of IL-1beta and iNOS mRNA were found. Our data for the first time demonstrate remote cytokine induction following focal brain ischemia and suggest that NMDA receptor-mediated signaling can activate inflammatory gene expression independently from the occurrence of neuronal cell death.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10996220     DOI: 10.1016/s0165-5728(00)00317-9

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  21 in total

Review 1.  Reprogramming the host response in bacterial meningitis: how best to improve outcome?

Authors:  M van der Flier; S P M Geelen; J L L Kimpen; I M Hoepelman; E I Tuomanen
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

Review 2.  Immune therapy in autism: historical experience and future directions with immunomodulatory therapy.

Authors:  Michael G Chez; Natalie Guido-Estrada
Journal:  Neurotherapeutics       Date:  2010-07       Impact factor: 7.620

Review 3.  Post-stroke inflammatory response: effects of stroke evolution and outcome.

Authors:  Kiat T Tan; Gregory Y H Lip; Andrew D Blann
Journal:  Curr Atheroscler Rep       Date:  2003-07       Impact factor: 5.113

4.  Neuron-astrocyte signaling network in spinal cord dorsal horn mediates painful neuropathy of type 2 diabetes.

Authors:  Jacqueline R Dauch; Brandon M Yanik; Wilson Hsieh; Sang Su Oh; Hsinlin T Cheng
Journal:  Glia       Date:  2012-05-09       Impact factor: 7.452

5.  Effects of interleukin-1ß on cortical spreading depolarization and cerebral vasculature.

Authors:  Frank Richter; Annett Eitner; Johannes Leuchtweis; Reinhard Bauer; Alfred Lehmenkühler; Hans-Georg Schaible
Journal:  J Cereb Blood Flow Metab       Date:  2016-01-01       Impact factor: 6.200

Review 6.  T-cell cytokines in injury-induced neural damage and repair.

Authors:  Michael Schroeter; Sebastian Jander
Journal:  Neuromolecular Med       Date:  2005       Impact factor: 3.843

7.  Ketamine alters the neurogenesis of rat cortical neural stem progenitor cells.

Authors:  Chaoxuan Dong; Cynthia R Rovnaghi; K J S Anand
Journal:  Crit Care Med       Date:  2012-08       Impact factor: 7.598

8.  Slit modulates cerebrovascular inflammation and mediates neuroprotection against global cerebral ischemia.

Authors:  Tamer Altay; Bethann McLaughlin; Jane Y Wu; T S Park; Jeffrey M Gidday
Journal:  Exp Neurol       Date:  2007-07-26       Impact factor: 5.330

9.  L-arginine and Alzheimer's disease.

Authors:  Jing Yi; Laura L Horky; Avi L Friedlich; Ying Shi; Jack T Rogers; Xudong Huang
Journal:  Int J Clin Exp Pathol       Date:  2008-10-02

10.  Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.

Authors:  Udi Vazana; Ronel Veksler; Gaby S Pell; Ofer Prager; Michael Fassler; Yoash Chassidim; Yiftach Roth; Hamutal Shahar; Abraham Zangen; Ruggero Raccah; Emanuela Onesti; Marco Ceccanti; Claudio Colonnese; Antonio Santoro; Maurizio Salvati; Alessandro D'Elia; Valter Nucciarelli; Maurizio Inghilleri; Alon Friedman
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.